About Innate Pharma SA
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma SA (IPHA) Stock Score & Signals
Innate Pharma SA (IPHA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 12 out of 100.
2BB score and signals
Innate Pharma SA’s current 2BB score is 12 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 87 | Very High (provisional) |
Company facts
| Founded | 1999 |
| Employees | 120 |
| 52-week range | $1.17 – $2.71 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.0606 | — | $2.33M |
| 2026-09-17 | — | -0.0707 | — | $8.08M |